Advertisement

Topics

Apellis Pharmaceuticals raises another $60 million to fund autoimmune program

07:17 EDT 11 Aug 2017 | thePharmaLetter

Privately-held Apellis Pharmaceuticals, a biotech company based in Kentucky, USA, has closed a financing…

Original Article: Apellis Pharmaceuticals raises another $60 million to fund autoimmune program

NEXT ARTICLE

More From BioPortfolio on "Apellis Pharmaceuticals raises another $60 million to fund autoimmune program"

Quick Search
Advertisement
 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...